• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高甲硫氨酸血症导致同型胱氨酸尿症转基因I278T小鼠模型出现致命性出血并增加死亡率。

Hypermethioninemia Leads to Fatal Bleeding and Increased Mortality in a Transgenic I278T Mouse Model of Homocystinuria.

作者信息

Park Insun, Johnson Linda K, Cox Allaura, Branchford Brian R, Di Paola Jorge, Bublil Erez M, Majtan Tomas

机构信息

Section of Genetics & Metabolism, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.

出版信息

Biomedicines. 2020 Jul 24;8(8):244. doi: 10.3390/biomedicines8080244.

DOI:10.3390/biomedicines8080244
PMID:32722248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7459533/
Abstract

Severely elevated plasma homocysteine and methionine lead to thromboembolic events and strokes in homocystinuric (HCU) patients. Mouse models of HCU failed to exhibit prothrombotic phenotype, presumably due to lack of hypermethioninemia. We evaluated the impact of hypermethioninemia together with hyperhomocysteinemia on murine HCU phenotype and compared the efficacy of the current and novel therapies for HCU. High methionine intake decreased survival of I278T mice, which died from intestinal bleeding with hepatic and pancreatic failure. I278T mice on normal or increased methionine intake developed endothelial dysfunction, but paradoxically demonstrated delayed occlusion in an induced arterial thrombosis model. RNA-seq analysis suggested that expression of coagulation factor XI (FXI) is downregulated in livers of I278T mice. Indeed, plasma concentrations of FXI were decreased in I278T mice on normal diet and further reduced by increased methionine intake. Dietary methionine restriction normalized the observed phenotype. Similarly, treatment with OT-58, a novel enzyme therapy for HCU, corrected the phenotype in I278T mice regardless of their dietary methionine intake. Hypermethioninemia does not contribute to prothrombotic phenotype in murine HCU. Downregulation of FXI may contribute to the lack of prothrombotic tendency in I278T mice. Methionine restriction or treatment with OT-58 corrects vascular disease in the I278T mouse model of HCU.

摘要

血浆同型半胱氨酸和蛋氨酸严重升高会导致同型胱氨酸尿症(HCU)患者发生血栓栓塞事件和中风。HCU小鼠模型未能表现出促血栓形成表型,可能是由于缺乏高蛋氨酸血症。我们评估了高蛋氨酸血症与高同型半胱氨酸血症对小鼠HCU表型的影响,并比较了当前和新型HCU疗法的疗效。高蛋氨酸摄入降低了I278T小鼠的存活率,这些小鼠死于肠道出血伴肝和胰腺衰竭。正常或增加蛋氨酸摄入的I278T小鼠出现内皮功能障碍,但在诱导性动脉血栓形成模型中却表现出延迟闭塞。RNA测序分析表明,I278T小鼠肝脏中凝血因子XI(FXI)的表达下调。事实上,正常饮食的I278T小鼠血浆FXI浓度降低,蛋氨酸摄入增加使其进一步降低。饮食中蛋氨酸限制可使观察到的表型正常化。同样,用OT-58(一种新型的HCU酶疗法)治疗,无论I278T小鼠的饮食蛋氨酸摄入量如何,均可纠正其表型。高蛋氨酸血症对小鼠HCU的促血栓形成表型无影响。FXI的下调可能导致I278T小鼠缺乏促血栓形成倾向。蛋氨酸限制或用OT-58治疗可纠正HCU的I278T小鼠模型中的血管疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e368/7459533/9c57c591cf0a/biomedicines-08-00244-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e368/7459533/67cb3b639d3b/biomedicines-08-00244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e368/7459533/ea31edf7d386/biomedicines-08-00244-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e368/7459533/f9c845b690ec/biomedicines-08-00244-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e368/7459533/5d8ba3b8f9b7/biomedicines-08-00244-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e368/7459533/72763e9c02c6/biomedicines-08-00244-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e368/7459533/9c57c591cf0a/biomedicines-08-00244-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e368/7459533/67cb3b639d3b/biomedicines-08-00244-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e368/7459533/ea31edf7d386/biomedicines-08-00244-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e368/7459533/f9c845b690ec/biomedicines-08-00244-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e368/7459533/5d8ba3b8f9b7/biomedicines-08-00244-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e368/7459533/72763e9c02c6/biomedicines-08-00244-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e368/7459533/9c57c591cf0a/biomedicines-08-00244-g006.jpg

相似文献

1
Hypermethioninemia Leads to Fatal Bleeding and Increased Mortality in a Transgenic I278T Mouse Model of Homocystinuria.高甲硫氨酸血症导致同型胱氨酸尿症转基因I278T小鼠模型出现致命性出血并增加死亡率。
Biomedicines. 2020 Jul 24;8(8):244. doi: 10.3390/biomedicines8080244.
2
Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine-restricted diet or enzyme replacement therapy.蛋氨酸限制饮食或酶替代疗法对高胱氨酸尿症小鼠行为、身体成分和血管表型的影响。
FASEB J. 2019 Nov;33(11):12477-12486. doi: 10.1096/fj.201901203R. Epub 2019 Aug 26.
3
Interplay of Enzyme Therapy and Dietary Management of Murine Homocystinuria.酶治疗与饮食管理在治疗鼠同型胱氨酸尿症中的相互作用。
Nutrients. 2020 Sep 22;12(9):2895. doi: 10.3390/nu12092895.
4
Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk.胱硫醚β合酶缺乏型高同型半胱氨酸血症小鼠模型中的长期甜菜碱治疗:随着时间的推移疗效降低,表明同型半胱氨酸升高与血栓形成风险之间存在显著的阈值效应。
Mol Genet Metab. 2012 Mar;105(3):395-403. doi: 10.1016/j.ymgme.2011.11.190. Epub 2011 Dec 2.
5
An orally administered enzyme therapeutic for homocystinuria that suppresses homocysteine by metabolizing methionine in the gastrointestinal tract.一种用于同型胱氨酸尿症的口服酶疗法,通过在胃肠道中代谢蛋氨酸来抑制同型半胱氨酸。
Mol Genet Metab. 2023 Aug;139(4):107653. doi: 10.1016/j.ymgme.2023.107653. Epub 2023 Jul 12.
6
Expression of mutant human cystathionine beta-synthase rescues neonatal lethality but not homocystinuria in a mouse model.突变型人类胱硫醚β-合酶的表达挽救了小鼠模型中的新生儿致死性,但未挽救同型胱氨酸尿症。
Hum Mol Genet. 2005 Aug 1;14(15):2201-8. doi: 10.1093/hmg/ddi224. Epub 2005 Jun 22.
7
Deciphering pathophysiological mechanisms underlying cystathionine beta-synthase-deficient homocystinuria using targeted metabolomics, liver proteomics, sphingolipidomics and analysis of mitochondrial function.应用靶向代谢组学、肝蛋白质组学、鞘脂组学和线粒体功能分析破译胱硫醚β-合酶缺乏性高同型半胱氨酸尿症的病理生理机制。
Redox Biol. 2024 Jul;73:103222. doi: 10.1016/j.redox.2024.103222. Epub 2024 Jun 4.
8
Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria.酶替代疗法改善了小鼠同型胱氨酸尿症的多种症状。
Mol Ther. 2018 Mar 7;26(3):834-844. doi: 10.1016/j.ymthe.2017.12.014. Epub 2017 Dec 19.
9
Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice.在纠正胱硫醚β-合成酶(CBS)缺陷小鼠的表型方面,补充甜菜碱不如限制蛋氨酸有效。
J Inherit Metab Dis. 2016 Jan;39(1):39-46. doi: 10.1007/s10545-015-9883-z. Epub 2015 Aug 1.
10
Taurine alleviates repression of betaine-homocysteine -methyltransferase and significantly improves the efficacy of long-term betaine treatment in a mouse model of cystathionine β-synthase-deficient homocystinuria.牛磺酸缓解甜菜碱-同型半胱氨酸 -N-甲基转移酶的抑制作用,并显著提高胱硫醚 β-合酶缺乏型高同型半胱氨酸尿症小鼠模型中长期甜菜碱治疗的疗效。
FASEB J. 2019 May;33(5):6339-6353. doi: 10.1096/fj.201802069RR. Epub 2019 Feb 15.

引用本文的文献

1
Deciphering pathophysiological mechanisms underlying cystathionine beta-synthase-deficient homocystinuria using targeted metabolomics, liver proteomics, sphingolipidomics and analysis of mitochondrial function.应用靶向代谢组学、肝蛋白质组学、鞘脂组学和线粒体功能分析破译胱硫醚β-合酶缺乏性高同型半胱氨酸尿症的病理生理机制。
Redox Biol. 2024 Jul;73:103222. doi: 10.1016/j.redox.2024.103222. Epub 2024 Jun 4.
2
Long-term functional correction of cystathionine β-synthase deficiency in mice by adeno-associated viral gene therapy.腺相关病毒基因治疗纠正胱硫醚β-合酶缺乏症小鼠的长期功能障碍。
J Inherit Metab Dis. 2021 Nov;44(6):1382-1392. doi: 10.1002/jimd.12437. Epub 2021 Oct 11.
3

本文引用的文献

1
Classical homocystinuria: From cystathionine beta-synthase deficiency to novel enzyme therapies.经典同型胱氨酸尿症:从胱硫醚β合酶缺乏症到新型酶治疗。
Biochimie. 2020 Jun;173:48-56. doi: 10.1016/j.biochi.2019.12.007. Epub 2019 Dec 16.
2
Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine-restricted diet or enzyme replacement therapy.蛋氨酸限制饮食或酶替代疗法对高胱氨酸尿症小鼠行为、身体成分和血管表型的影响。
FASEB J. 2019 Nov;33(11):12477-12486. doi: 10.1096/fj.201901203R. Epub 2019 Aug 26.
3
Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria.
Analysis of differential neonatal lethality in cystathionine β-synthase deficient mouse models using metabolic profiling.
利用代谢组学分析胱硫醚-β-合酶缺陷型小鼠模型中的新生儿差异致死性。
FASEB J. 2021 Jun;35(6):e21629. doi: 10.1096/fj.202100302R.
酶替代疗法改善了小鼠同型胱氨酸尿症的多种症状。
Mol Ther. 2018 Mar 7;26(3):834-844. doi: 10.1016/j.ymthe.2017.12.014. Epub 2017 Dec 19.
4
Enzyme replacement therapy prevents loss of bone and fat mass in murine homocystinuria.酶替代疗法可预防鼠同型胱氨酸尿症中骨量和脂肪量的丢失。
Hum Mutat. 2018 Feb;39(2):210-218. doi: 10.1002/humu.23360. Epub 2017 Nov 13.
5
Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine homocystinuria.酶替代疗法可预防小鼠同型胱氨酸尿症中的新生儿死亡、肝损伤和骨质疏松症。
FASEB J. 2017 Dec;31(12):5495-5506. doi: 10.1096/fj.201700565R. Epub 2017 Aug 16.
6
Engineering and Characterization of an Enzyme Replacement Therapy for Classical Homocystinuria.经典同型胱氨酸尿症酶替代治疗的工程与表征。
Biomacromolecules. 2017 Jun 12;18(6):1747-1761. doi: 10.1021/acs.biomac.7b00154. Epub 2017 May 1.
7
Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency.胱硫醚β-合酶缺乏症的诊断与管理指南。
J Inherit Metab Dis. 2017 Jan;40(1):49-74. doi: 10.1007/s10545-016-9979-0. Epub 2016 Oct 24.
8
Homocysteine lowering for stroke prevention: Unravelling the complexity of the evidence.同型半胱氨酸降低与卒中预防:揭示证据的复杂性。
Int J Stroke. 2016 Oct;11(7):744-7. doi: 10.1177/1747493016662038. Epub 2016 Jul 26.
9
Gastrointestinal Issues in Liver Disease.肝病中的胃肠道问题。
Crit Care Clin. 2016 Jul;32(3):371-84. doi: 10.1016/j.ccc.2016.03.007.
10
Targeting Cystathionine Beta-Synthase Misfolding in Homocystinuria by Small Ligands: State of the Art and Future Directions.通过小分子配体靶向高胱氨酸尿症中的胱硫醚β-合酶错误折叠:现状与未来方向
Curr Drug Targets. 2016;17(13):1455-70. doi: 10.2174/1389450117666160302094910.